Sesen Bio, Inc. Business Finance Contracts & Agreements
45 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (3)
- Purchase Agreements (4)
- Registration Rights Agreements (3)
- Release Agreements (1)
- Share Agreements (1)
- Stock Agreements (10)
- Underwriting Agreements (6)
- Warrant Agreements (14)
- 2024 Form of Stock Option Agreement (Filed With SEC on April 1, 2024)
- Carisma Therapeutics Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on March 8, 2023)
- Registration Rights Agreement, dated March 7, 2023 (Filed With SEC on March 8, 2023)
- Asset Purchase Agreement, dated as of July 15, 2022 by and among Sesen Bio, Inc., F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Filed With SEC on July 18, 2022)
- Amendment No. 1 to the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on May 3, 2021)
- Stock Option Award Agreement, dated August 1, 2019, by and between Sesen Bio, Inc. and Monica Forbes (Filed With SEC on November 12, 2019)
- Amendment to Securities Purchase Agreement, dated October 28, 2019, by and among Sesen Bio, Inc. and the undersigned parties thereto (Filed With SEC on October 29, 2019)
- Form of 2018 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)
- Form of 2018 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)
- Form of 2017 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)
- Form of 2017 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)
- Press Release, dated August 26, 2019 (Filed With SEC on August 26, 2019)
- Form of Warrant (Filed With SEC on June 19, 2019)
- Underwriting Agreement, dated June 19, 2019 (Filed With SEC on June 19, 2019)
- Stock Option Award Agreement, dated December 3, 2018, by and between Sesen Bio, Inc. and Dennis Kim, M.D (Filed With SEC on March 1, 2019)
- Stock Option Award Agreement, dated August 7, 2018, by and between Sesen Bio, Inc. and Thomas R. Cannell, D.V.M (Filed With SEC on March 1, 2019)
- Underwriting Agreement, dated May 30, 2018 (Filed With SEC on June 1, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on March 23, 2018)
- Form of Warrant (Filed With SEC on March 23, 2018)
- Form of Common Warrant (Filed With SEC on November 3, 2017)
- Form of Pre-funded Warrant (Filed With SEC on November 3, 2017)
- Underwriting Agreement, dated as of November 1, 2017, by and between Eleven Biotherapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 3, 2017)
- Form of Common Warrant (Filed With SEC on October 31, 2017)
- Form of Pre-Funded Warrant (Filed With SEC on October 31, 2017)
- Form of Underwriting Agreement (Filed With SEC on October 31, 2017)
- Form of Common Warrant (Filed With SEC on October 30, 2017)
- Form of Pre-Funded Warrant (Filed With SEC on October 30, 2017)
- Form of Underwriting Agreement (Filed With SEC on October 30, 2017)
- Form of Underwriting Agreement (Filed With SEC on October 17, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED & RESTATED EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on September 21, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on September 21, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 21, 2016)
- SHARE PURCHASE AGREEMENT by andamong ELEVEN BIOTHERAPEUTICS, INC., VIVENTIA BIO INC., THESHAREHOLDERS OF VIVENTIA BIO INC. (NAMED HEREIN) AND SOLELY IN ITS CAPACITY ASSELLER... (Filed With SEC on September 21, 2016)
- CONSENT AND THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 25, 2016)
- WARRANT TO PURCHASESTOCK (Filed With SEC on December 19, 2014)
- SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on December 19, 2014)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 1, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 1, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on January 23, 2014)
- ELEVEN BIOTHERAPEUTICS, INC. Restricted Stock Agreement (Filed With SEC on January 23, 2014)
